Ấn Độ không quan ngại về tác dụng phụ của vaccine AstraZeneca

Ngày 17/3, quan chức y tế Ấn Độ Vinod Kumar Paul khẳng định rằng nước này không lo ngại về tác dụng phụ tiềm ẩn của vaccine AstraZeneca đang được sử dụng trong chương trình tiêm chủng quốc gia.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh